The purpose of this study is to determine the safety and dose of 3 different chemotherapy drugs in dogs with lymphoma (cancer). Dogs with a confirmed diagnosis of lymphoma (just diagnosed or relapsed after treatment) with no other significant health problems are eligible. Each dog will receive 1 of the 3 chemotherapy drugs being evaluated, and depending on how your dog responds to the drug, additional doses may be given.
Once your dog is enrolled, costs associated with study-related sample collection, treatment with the study drug and any side effects will be paid for by the study. Owners will also receive a financial credit to apply towards future non-study lymphoma treatment for their dog.
The chemotherapy drug is given daily for 5 days, and your dog will stay at Penn Vet during that treatment period. You will be required to bring your dog back to Penn Vet after the treatment is completed for a minimum of 28 days.
Please contact the VCIC @ (215) 573-0302 or vcic@vet.upenn.edu if you would like more information about this clinical study.